<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34372918</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>28</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2047-9158</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Aug</Month><Day>09</Day></PubDate></JournalIssue><Title>Translational neurodegeneration</Title><ISOAbbreviation>Transl Neurodegener</ISOAbbreviation></Journal><ArticleTitle>The&#xa0;Gold Coast criteria increases the diagnostic sensitivity for amyotrophic lateral sclerosis in a Chinese population.</ArticleTitle><Pagination><StartPage>28</StartPage><MedlinePgn>28</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">28</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s40035-021-00253-2</ELocationID><Abstract><AbstractText Label="OBJECTIVES">The aim of this study was to assess and compare the diagnostic utility of a new diagnostic criteria for amyotrophic lateral sclerosis (ALS), abbreviated as the 'Gold Coast Criteria', with the revised El Escorial (rEEC) and Awaji criteria.</AbstractText><AbstractText Label="METHODS">Clinical and electrophysiological data of 1185 patients from January 2014 to December 2019 in the Peking Union Medical College Hospital ALS database were reviewed. The sensitivity of the Gold Coast criteria was compared to that of the possible rEEC and Awaji criteria (defined by the proportion of patients categorized as definite, probable, or possible ALS).</AbstractText><AbstractText Label="RESULTS">A final diagnosis of ALS was recorded in 1162 patients. The sensitivity of the Gold Coast criteria (96.6%, 95% confidence interval [CI]&#x2009;=&#x2009;95.3%-97.5%) was greater than that of the rEEC (85.1%, 95%CI&#x2009;=&#x2009;82.9%-87.1%) and Awaji (85.3%, 95%CI&#x2009;=&#x2009;83.2%-87.3%). In addition, the sensitivity of the novel criteria maintained robust across subgroups, and the advantage was more prominent in limb-onset ALS patients and those who completed electromyographic tests. In those who did not achieve any of the rEEC diagnostic categories, the sensitivity of Gold Coast criteria was 84.4%.</AbstractText><AbstractText Label="CONCLUSIONS">The current study demonstrated that the Gold Coast criteria exhibited greater diagnostic sensitivity than the rEEC and Awaji criteria in a Chinese ALS population. The application of the Gold Coast criteria should be considered in clinical practice and future therapeutic trials.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Dongchao</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking Union Medical College Hospital, Beijing, 100730, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Xunzhe</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking Union Medical College Hospital, Beijing, 100730, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yanying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking Union Medical College Hospital, Beijing, 100730, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Di</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking Union Medical College Hospital, Beijing, 100730, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Xiaohan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking Union Medical College Hospital, Beijing, 100730, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cai</LastName><ForeName>Zhengyi</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking Union Medical College Hospital, Beijing, 100730, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jinyue</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking Union Medical College Hospital, Beijing, 100730, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Mingsheng</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking Union Medical College Hospital, Beijing, 100730, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cui</LastName><ForeName>Liying</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-5369-1541</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Peking Union Medical College Hospital, Beijing, 100730, China. pumchcuily@yahoo.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Center, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China. pumchcuily@yahoo.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>08</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Transl Neurodegener</MedlineTA><NlmUniqueID>101591861</NlmUniqueID><ISSNLinking>2047-9158</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004576" MajorTopicYN="N">Electromyography</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011159" MajorTopicYN="Y">Population Surveillance</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012042" MajorTopicYN="N">Registries</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Diagnostic criteria</Keyword><Keyword MajorTopicYN="N">Gold Coast</Keyword><Keyword MajorTopicYN="N">Sensitivity</Keyword></KeywordList><CoiStatement>None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>5</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>7</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>8</Month><Day>10</Day><Hour>5</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>8</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34372918</ArticleId><ArticleId IdType="pmc">PMC8351337</ArticleId><ArticleId IdType="doi">10.1186/s40035-021-00253-2</ArticleId><ArticleId IdType="pii">10.1186/s40035-021-00253-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kiernan MC, Vucic S, Talbot K, McDermott CJ, Hardiman O, Shefner JM, et al. Improving clinical trial outcomes in amyotrophic lateral sclerosis. Nat Rev Neurol. 2020:1&#x2013;15.</Citation></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2000;1(5):293&#x2013;9.&#xa0;</Citation><ArticleIdList><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Traynor BJ, Codd MB, Corr B, Forde C, Frost E, Hardiman OM. Clinical features of amyotrophic lateral sclerosis according to the El Escorial and Airlie house diagnostic criteria: a population-based study. Arch Neurol. 2000;57(8):1171&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">10927797</ArticleId></ArticleIdList></Reference><Reference><Citation>de Carvalho M, Dengler R, Eisen A, England JD, Kaji R, Kimura J, et al. Electrodiagnostic criteria for diagnosis of ALS. Clin Neurophysiol. 2008;119(3):497&#x2013;503.</Citation><ArticleIdList><ArticleId IdType="pubmed">18164242</ArticleId></ArticleIdList></Reference><Reference><Citation>Douglass CP, Kandler RH, Shaw PJ, McDermott CJ. An evaluation of neurophysiological criteria used in the diagnosis of motor neuron disease. J Neurol Neurosurg Psychiatry. 2010;81(6):646&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">20522872</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho MD, Swash M. Awaji diagnostic algorithm increases sensitivity of El Escorial criteria for ALS diagnosis. Amyotroph Lateral Scler. 2009;10(1):53&#x2013;7</Citation><ArticleIdList><ArticleId IdType="pubmed">18985466</ArticleId></ArticleIdList></Reference><Reference><Citation>Li D, Liu M, Cui B, Fang J, Guan Y, Ding Q, et al. The Awaji criteria increases the diagnostic sensitivity of the revised El Escorial criteria for amyotrophic lateral sclerosis diagnosis in a Chinese population. PLoS One. 2017;12(3):e171522.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5332033</ArticleId><ArticleId IdType="pubmed">28249004</ArticleId></ArticleIdList></Reference><Reference><Citation>Boekestein WA, Kleine BU, Hageman G, Schelhaas HJ, Zwarts MJ. Sensitivity and specificity of the 'Awaji' electrodiagnostic criteria for amyotrophic lateral sclerosis: retrospective comparison of the Awaji and revised El Escorial criteria for ALS. Amyotroph Lateral Scler. 2010;11(6):497&#x2013;501.</Citation><ArticleIdList><ArticleId IdType="pubmed">20536375</ArticleId></ArticleIdList></Reference><Reference><Citation>Schrooten M, Smetcoren C, Robberecht W, Van Damme P. Benefit of the Awaji diagnostic algorithm for amyotrophic lateral sclerosis: a prospective study. Ann Neurol. 2011;70(1):79&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">21437935</ArticleId></ArticleIdList></Reference><Reference><Citation>Noto Y, Misawa S, Kanai K, Shibuya K, Isose S, Nasu S, et al. Awaji ALS criteria increase the diagnostic sensitivity in patients with bulbar onset. Clin Neurophysiol. 2012;123(2):382&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">21764635</ArticleId></ArticleIdList></Reference><Reference><Citation>Okita T, Nodera H, Shibuta Y, Nodera A, Asanuma K, Shimatani Y, et al. Can Awaji ALS criteria provide earlier diagnosis than the revised El Escorial criteria? J Neurol Sci. 2011;302(1&#x2013;2):29&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">21215419</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa J, Swash M, de Carvalho M. Awaji criteria for the diagnosis of amyotrophic lateral sclerosis:a systematic review. Arch Neurol. 2012;69(11):1410&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">22892641</ArticleId></ArticleIdList></Reference><Reference><Citation>Jang JS, Bae JS. AWAJI criteria are not always superior to the previous criteria: a meta-analysis. Muscle Nerve. 2015;51(6):822&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">25597926</ArticleId></ArticleIdList></Reference><Reference><Citation>Geevasinga N, Menon P, Scherman DB, Simon N, Yiannikas C, Henderson RD, et al. Diagnostic criteria in amyotrophic lateral sclerosis: a multicenter prospective study. Neurology. 2016;87(7):684&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">27440148</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnsen B, Pugdahl K, Fuglsang-Frederiksen A, Kollewe K, Paracka L, Dengler R, et al. Diagnostic criteria for amyotrophic lateral sclerosis: a multicentre study of inter-rater variation and sensitivity. Clin Neurophysiol. 2019;130(2):307&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">30573424</ArticleId></ArticleIdList></Reference><Reference><Citation>Shefner JM, Al-Chalabi A, Baker MR, Cui LY, de Carvalho M, Eisen A, et al. A proposal for new diagnostic criteria for ALS. Clin Neurophysiol. 2020;131(8):1975&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">32387049</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnsen B. Diagnostic criteria for amyotrophic lateral sclerosis from El Escorial to Gold Coast. Clin Neurophysiol. 2020;131(8):1962&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">32418823</ArticleId></ArticleIdList></Reference><Reference><Citation>Tai H, Cui L, Liu M, Guan Y, Li X, Shen D, et al. Creatine kinase level and its relationship with quantitative electromyographic characteristics in amyotrophic lateral sclerosis. Clin Neurophysiol. 2018;129(5):926&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">29550653</ArticleId></ArticleIdList></Reference><Reference><Citation>Zoccolella S, Beghi E, Palagano G, Fraddosio A, Samarelli V, Lamberti P, et al. Predictors of delay in the diagnosis and clinical trial entry of amyotrophic lateral sclerosis patients: a population-based study. J Neurol Sci. 2006;250(1&#x2013;2):45&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">16920152</ArticleId></ArticleIdList></Reference><Reference><Citation>Ince PG, Evans J, Knopp M, Forster G, Hamdalla HH, Wharton SB, et al. Corticospinal tract degeneration in the progressive muscular atrophy variant of ALS. Neurology. 2003;60(8):1252&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">12707426</ArticleId></ArticleIdList></Reference><Reference><Citation>Riku Y, Atsuta N, Yoshida M, Tatsumi S, Iwasaki Y, Mimuro M, et al. Differential motor neuron involvement in progressive muscular atrophy: a comparative study with amyotrophic lateral sclerosis. BMJ Open. 2014;4(5):e5213. doi: 10.1136/bmjopen-2014-005213.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2014-005213</ArticleId><ArticleId IdType="pmc">PMC4025414</ArticleId><ArticleId IdType="pubmed">24833696</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Mora G, Leone M, Mazzini L, Cocito D, Giordana MT, et al. Early symptom progression rate is related to ALS outcome: a prospective population-based study. Neurology. 2002;59(1):99&#x2013;103.</Citation><ArticleIdList><ArticleId IdType="pubmed">12105314</ArticleId></ArticleIdList></Reference><Reference><Citation>Upadhyay V, Katz M, Kiernan M, Henderson R. Review of the revised amyotrophic lateral sclerosis diagnostic criteria. Clin Neurophysiol. 2020;131(8):1767&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">32504937</ArticleId></ArticleIdList></Reference><Reference><Citation>Hannaford A, Pavey N, van den Bos M, Geevasinga N, Menon P, Shefner JM, et al. Diagnostic utility of Gold Coast criteria in amyotrophic lateral sclerosis. Ann Neurol. 2021;89(5):979&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pubmed">33565111</ArticleId></ArticleIdList></Reference><Reference><Citation>Higashihara M, Sonoo M, Imafuku I, Fukutake T, Kamakura K, Inoue K, et al. Fasciculation potentials in amyotrophic lateral sclerosis and the diagnostic yield of the Awaji algorithm. Muscle Nerve. 2012;45(2):175&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">22246871</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu MS, Cui LY, Fan DS. Age at onset of amyotrophic lateral sclerosis in China. Acta Neurol Scand. 2014;129(3):163&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">23819875</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowland LP. Progressive muscular atrophy and other lower motor neuron syndromes of adults. Muscle Nerve. 2010;41(2):161&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">20082312</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahrizaila N, Sobue G, Kuwabara S, Kim SH, Birks C, Fan DS, et al. Amyotrophic lateral sclerosis and motor neuron syndromes in Asia. J Neurol Neurosurg Psychiatry. 2016;87(8):821&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">27093948</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou ZY, Liu MS, Li XG, Cui LY. H46R SOD1 mutation is consistently associated with a relatively benign form of amyotrophic lateral sclerosis with slow progression. Amyotroph Lateral Scler Frontotemporal Degener. 2016;17(7&#x2013;8):610&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">27348463</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>